Skip to main content
Advertisement
Advertisement

EW

EW logo

Edwards Lifesciences Corp

88.38
USD
Sponsored
+0.13
+0.14%
Sep 18, 12:37 UTC -4
Open

EW Earnings Reports

Positive Surprise Ratio

EW beat 26 of 42 last estimates.

62%

Next Report

Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$1.73B
/
$0.75
Implied change from Q2 26 (Revenue/ EPS)
-0.85%
/
-3.85%
Implied change from Q3 25 (Revenue/ EPS)
+11.14%
/
+11.94%

Edwards Lifesciences Corp earnings per share and revenue

On Jul 23, 2026, EW reported earnings of 0.78 USD per share (EPS) for Q2 26, beating the estimate of 0.76 USD, resulting in a 2.27% surprise. Revenue reached 1.74 billion, compared to an expected 1.75 billion, with a -0.58% difference. The market reacted with a -1.42% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 27 analysts forecast an EPS of 0.75 USD, with revenue projected to reach 1.73 billion USD, implying an decrease of -3.85% EPS, and decrease of -0.85% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
NANO-X IMAGING LTD Ordinary Shares
Report Date
Sep 09, 2026 For Q2 26
Estimate
-$0.16
Actual
-$0.80
Surprise
-380.19%
FAQ
For Q2 2026, Edwards Lifesciences Corp reported EPS of $0.78, beating estimates by 2.27%, and revenue of $1.74B, -0.58% below expectations.
The stock price moved down -1.42%, changed from $83.82 before the earnings release to $82.63 the day after.
The next earning report is scheduled for Oct 28, 2026.
Based on 27 analysts, Edwards Lifesciences Corp is expected to report EPS of $0.75 and revenue of $1.73B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement